Skip to main content

Fluidigm Inks Scandinavia Distribution Deal

NEW YORK (GenomeWeb News) – Fluidigm today said that it has signed an agreement with AH Diagnostics to serve as its exclusive distributor in Sweden, Norway, Denmark, Iceland, and Finland.

Starting Feb. 1, Aarhus, Denmark-based AH will offer Fluidigm's portfolio of BioMark HD, EP1, and Access Array Systems and its arrays for a variety of genomic applications, including the new Deltagene and SNPtype arrays. Financial and other terms of the deal were not disclosed.

"AH diagnostics has built a strong reputation across Scandinavia for addressing the needs of the life science research community," Dominique Remy-Renou, VP of European Commercial Operations for Fluidigm Europe BV, said in a statement. "We look forward to helping them bring the tools needed to solve some of today's most complex genetic questions in biology all the way down to the single cell."

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.